Abstract
Background
It is well known that thyroid nodules are common among the general population. Despite the fact that only 4–8% are clinically detectable, a higher percentage ranging between 13–67% are identified with ultrasonography. Many studies have shown that malignancy can be detected in 5% of these nodules irrespective of their size. Nowadays, total thyroidectomy seems to be the most appropriate operation, even for benign thyroid diseases. We conducted this prospective study in order to assess the true incidence of occult thyroid cancer in benign thyroid disease specimens and explore any associated factors. Finally, we wanted to appraise whether total thyroidectomy is indeed justified based on these grounds.
Materials and methods
From March 2010 to March 2014, we operated on 114 patients for benign thyroid pathology; the patients had a mean age of 52.24 years (17–81 years). Thirty patients were eventually found to have occult cancer (19 microcarcinomas and 11 macrocarcinomas).We compared the patients with and without cancer in order to determine any predictive factors.
Results
Only the underlying histology was found to be related to the presence of cancer. Patients with cancer had a higher than expected percentage of Hashimoto thyroiditis while patients without cancer were found to have a greater than anticipated percentage of nodular hyperplasia. None of the other quantitative or qualitative factors were found to be a significant predictor of cancer.
Conclusion
After performing a proper workup as indicated by the guidelines, a high risk for occult thyroid cancer still remains (at least in the Greek population), which justifies the selection of total thyroidectomy for the management of benign thyroid pathologies. Only the underlying histology is associated with the presence of cancer since Hashimoto thyroiditis seems to be a risk factor.
Similar content being viewed by others
References
Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 1994;154:1838–40.
Yeung MJ, Serpell JW. Management of the solitary thyroid nodule. Oncologist 2008;13:105–12.
Giles WH, Maclellan RA, Gawande AA, et al. False negative cytology in large thyroid nodules. Ann Surg Oncol 2014;22:152–7.
Yoon JH, Kwak JY, Moon HJ, et al. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger. Thyroid 2011; 2:993–1000.
Kim ES, Lim DJ, Baek KH, et al. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 2010;20:885–91.
Heyman S, Pirenne Y, Van Elst F, et al. Is FNAC (fine needle aspiration cytology) a useful tool in detection of malignancy in thyroid surgery? A single institution experience. Acta Chir Belg 2014;114:115–7.
Alecu L, Barbulescu M, Ursut B, et al. Occult thyroid carcinoma in our experience — should we reconsider total thyroidectomy for benign thyroid pathology? Chirurgia (Bucur) 2014;109:191–7.
Sakorafas GH, Giotakis J, Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 2005;31:423–38.
Agarwal G, Aggarwal V. Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review. World J Surg 2008;32:1313–24.
Bomeli SR, LeBeau SO, Ferris RL. Evaluation of a thyroid nodule. Otolaryngol Clin North Am 2010;43:229–38.
McCoy KL, Jabbour N, Ogilvie JB, et al. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery 2007;142:837–44.
Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995;16:487–94.
Hegedus L. Clinical practice. The thyroid nodule. N Engl J Med 2004;351:1764–71.
Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;5:1941–6.
Fish SA, Langer JE, Mandel SJ. Sonographic imaging of thyroid nodules and cervical lymph nodes. Endocrinol Metab Clin North Am 2008;37:401–17.
Musholt TJ, Clerici T, Dralle H, et al. German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease. Langenbecks Arch Surg 2011;396:639–49.
Rayes N, Steinmuller T, Schroder S, et al. Bilateral subtotal thyroidectomy versus hemithyroidectomy plus subtotal resection (Dunhill procedure) for benign goiter: long-term results of a prospective, randomized study. World J Surg 2012;37:84–90.
Andaker L, Johansson K, Smeds S, Lennquist S. Surgery for hyperthyroidism: hemithyroidectomy plus contralateral resection or bilateral resection? A prospective randomized study of postoperative complications and long-term results. World J Surg 1992;16:765–9.
Barczynski M, Konturek A, Hubalewska-Dydejczyk A, et al. Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter. World J Surg 2010;34:1203–13.
Pappalardo G, Guadalaxara A, Frattaroli FM, et al. Total compared with subtotal thyroidectomy in benign nodular disease: personal series and review of published reports. Eur J Surg 1998;164:501–6.
Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011;17:456–520.
Feroci F, Rettori M, Borrelli A, et al. A systematic review and meta-analysis of total thyroidectomy versus bilateral subtotal thyroidectomy for Graves, disease. Surgery 2013;155:529–40.
Guo Z, Yu P, Liu Z, et al. Total thyroidectomy vs bilateral subtotal thyroidectomy in patients with Graves, diseases: a meta-analysis of randomized clinical trials. Clin Endocrinol (Oxf) 2013;79:739–46.
Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–214.
Kim ES, Lim DJ, Baek KH, et al. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 2010;20:885–91.
Mendelson AA, Tamilia M, Rivera J, et al. Predictors of malignancy in preoperative nondiagnostic biopsies of the thyroid. J Otolaryngol Head Neck Surg 2009;38:395–400.
Kamran SC, Marqusee E, Kim MI, et al. Thyroid nodule size and prediction of cancer. J Clin Endocrinol Metab 2013;98:564–70.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lanitis, S., Ganis, V., Sgourakis, G. et al. Occult cancer after thyroidectomy for benign thyroid disorders. Is total thyroidectomy justified based on these grounds?. Hellenic J Surg 87, 309–316 (2015). https://doi.org/10.1007/s13126-015-0231-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13126-015-0231-4